X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (198) 198
Publication (30) 30
Book Chapter (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (94) 94
index medicus (83) 83
visceral leishmaniasis (71) 71
parasitic diseases (68) 68
kala-azar (60) 60
nepal (55) 55
tropical medicine (55) 55
animals (49) 49
female (46) 46
male (44) 44
infectious diseases (42) 42
leishmaniasis, visceral - epidemiology (42) 42
leishmaniasis (41) 41
nepal - epidemiology (41) 41
parasitology (39) 39
india (37) 37
epidemiology (36) 36
research (36) 36
tropical diseases (34) 34
adult (32) 32
leishmaniasis, visceral - drug therapy (30) 30
diagnosis (27) 27
research article (27) 27
medicine (26) 26
arctic medicine. tropical medicine (25) 25
drug resistance (25) 25
leishmaniasis, visceral - diagnosis (25) 25
leishmaniasis, visceral - parasitology (25) 25
parasites (25) 25
public aspects of medicine (25) 25
public, environmental & occupational health (25) 25
microbiology (24) 24
adolescent (23) 23
leishmania donovani (23) 23
public health (23) 23
india - epidemiology (21) 21
leishmania donovani - isolation & purification (21) 21
risk factors (21) 21
infections (20) 20
bihar (19) 19
middle aged (19) 19
studies (19) 19
visceral (19) 19
young adult (19) 19
health aspects (18) 18
leishmaniasis, visceral - prevention & control (18) 18
neglected tropical diseases (18) 18
protozoal diseases (18) 18
analysis (17) 17
bangladesh (16) 16
care and treatment (16) 16
child (16) 16
direct agglutination-test (16) 16
drug therapy (16) 16
asia, south (15) 15
child, preschool (15) 15
immunology (15) 15
leishmania donovani - genetics (15) 15
phosphorylcholine - analogs & derivatives (15) 15
miltefosine (14) 14
antiprotozoal agents - administration & dosage (13) 13
antiprotozoal agents - therapeutic use (13) 13
infection (13) 13
kala azar (13) 13
leishmania donovani - drug effects (13) 13
prevalence (13) 13
disease transmission (12) 12
medical research (12) 12
medicine and health sciences (12) 12
sensitivity and specificity (12) 12
sudan (12) 12
elimination (11) 11
insecticides (11) 11
malaria (11) 11
patients (11) 11
biology (10) 10
biology and life sciences (10) 10
clinical trials (10) 10
endemic diseases (10) 10
health sciences (10) 10
leishmaniasis, visceral - transmission (10) 10
phlebotomus argentipes (10) 10
abridged index medicus (9) 9
antiprotozoal agents - pharmacology (9) 9
donovani (9) 9
households (9) 9
laboratories (9) 9
leishmania (9) 9
medicine, general & internal (9) 9
prospective studies (9) 9
sand & gravel (9) 9
sodium stibogluconate (9) 9
usage (9) 9
vector-borne diseases (9) 9
antibodies, protozoan - blood (8) 8
antigens (8) 8
donovani infection (8) 8
drug-resistance (8) 8
health facilities (8) 8
hospitals (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMJ (Online), ISSN 0959-8146, 2019, Volume 364, p. k5407
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2013, Volume 56, Issue 11, pp. 1530 - 1538
Journal Article
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 11/2017, Volume 11, Issue 11, p. e0005877
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 01/2013, Volume 13, Issue 1, pp. 37 - 37
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, p. e100220
Background: High frequency of relapse in miltefosine-treated visceral leishmaniasis (VL) patients in India and Nepal followed up for twelve months. Objective:... 
ORAL MILTEFOSINE | EFFICACY | MULTIDISCIPLINARY SCIENCES | PALESTINE REFUGEES | KALA-AZAR | INFECTION | DRUG-RESISTANCE | SEX-DIFFERENCES | PREVALENCE | SODIUM STIBOGLUCONATE | INDIA | Recurrence | Leishmania donovani - physiology | Parasitic Sensitivity Tests | Prospective Studies | Age Factors | Leishmania donovani - drug effects | Humans | Risk Factors | Child, Preschool | Male | Phosphorylcholine - analogs & derivatives | India | Leishmaniasis, Visceral - drug therapy | Treatment Failure | Adolescent | Sex Factors | Adult | Female | Leishmaniasis, Visceral - parasitology | Antiprotozoal Agents - therapeutic use | Child | Nepal | Phosphorylcholine - therapeutic use | Practice Guidelines as Topic | Kala-azar | Care and treatment | Comparative analysis | Health aspects | Drugs | Health sciences | Pediatrics | Medical services | Clinical trials | Infections | Parasites | Epidemiology | Risk factors | Regulatory approval | Immunology | Acquired immune deficiency syndrome--AIDS | Parasitic diseases | Visceral leishmaniasis | Safety engineering | Human immunodeficiency virus--HIV | Design standards | Children | Age | Public health | Spleen | Vector-borne diseases | Medical research | Gender differences | Pharmacology | Exposure | Leishmaniasis | Risk analysis | Patients | Medicine | Miltefosine | Pharmacokinetics | Ambulatory care | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article